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Liposomes have been widely researched as a delivery system and there have been many
manufacturing techniques used in the production of liposomal preparations, the most
common being extrusion method which will be introduced in this paper. However because
of the unique properties of liposomes and their susceptibility to chemical and physical
degradation, sterilisation remains an unresolved issue in the manufacturing of liposome-
based formulations. It is especially pertinent in the pharmaceutical industry where lipo-
somes are commonly prepared for intravenous administration. Currently, filtration and
aseptic manufacturing are recommended for the preparation of sterile liposomal products.
Newer aseptic manufacturing techniques such as dense gas techniques have been devised
to eliminate the need for terminal sterilisation. This paper will highlight the limitations of
the conventional techniques that are specific to the liposome preparation under the
respective sterilisation conditions specified by the 2011 British Pharmacopoeia to achieve
106 Sterility Assurance Level, as well as modifications incorporated in the newer steri-
lisation technologies to overcome these limitations. This paper will introduce these tech-
niques in brief, including their advantages and limitations.
ª 2013 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. All
rights reserved.1. Introduction can contain contaminants such as endotoxins, thereforeLiposomes are concentric lipid bilayer vesicles in which an
aqueous volume is encapsulated. They are commonly
formulated from phospholipids and sterols and may contain
hydrophilic polymer conjugated lipids. These ingredients can
be derived fromnatural sources such as egg, soy ormilkwhichacy, Faculty of Science, N




ang Pharmaceutical Univproduct sterilisation is required, especially when the end
product is designated for formulation of parenteral (mainly
intravenous) products. The composition of the preparation
will determine its physicochemical properties such as phase
transition temperature and these in turn determine its suit-
ability towards the various sterilisation techniques.ational University of Singapore, Block S4, 02-09, 18 Science Drive 4,
sity
ersity. Production and hosting by Elsevier B.V. All rights reserved.
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gradable delivery systems that can be used to solubilise sub-
stances with low aqueous solubility such as lipophilic drugs
which, if injected as a free drug, might precipitate in aqueous
blood media and contribute to the formation of a thrombus.
The entrapped drugs consequently are protected from physi-
ological degradation and released in a sustain-release
manner, enhancing their bioavailability and circulation time.
The therapeutic index of cytotoxic drugs such as anticancer
drugs can also be raised when their liposomal carriers are
affixed with cell-specific antibodies or ligands. In view of their
advantages as delivery systems, liposomes are increasingly
being researched and utilised in the pharmaceutical, food and
cosmetic industries. In the pharmaceutical industry, lipo-
somes are designed as carriers to deliver bioactive agents into
cells, immunological adjuvants and more recently, contrast
agents for molecular imaging [1].
In spite of all the advantages, much research is still required
before liposomes can be extensively utilised in pharmaceutical
formulations due to issues of stability, reproducibility, entrap-
ment efficiency, size distribution, short circulation half-life of
vesicles and more importantly, sterilisation [2]. The following
sections of this paper will summarise some of the degradation
mechanisms of liposomes and how these mechanisms will be
induced during the conventional sterilisation techniques (at
conditions specified by the 2011 British Pharmacopoeia),
therefore making these techniques unsuitable, to a certain
extent, in the manufacturing of liposomes.2. Common manufacturing techniques of
liposomal products
Liposomes of varying sizes and lamellarity are formed spon-
taneously when lipid components are introduced into an
aqueous environment. Due to the hydrophobic force, the
amphiphilic constituent molecules cluster into aggregates in
order to minimise the contact between their hydrophobic
portions and the surrounding aqueous environment, these
aggregates can be organised into liposomes if provided with
adequate amount of energy in the form of heating, sonication
or homogenisation. However, for liposomal preparations to be
acceptable as pharmaceuticals, these liposomes must be
processed to fulfil criteria such as a defined size and narrow
size distribution hence various manufacturing techniques
have been developed to achieve the uniformity of the vesicles.
One of the most common manufacturing techniques in
industries is the extrusion method. Liposomes are prepared
prior to the extrusion procedure by a simple process of dis-
solving the lipid component in an organic solvent before
emulsifying this mixture in an aqueous phase and slowly
evaporating the organic solvent. The liposomes formed are
then, in their liquid-crystalline state, extruded through poly-
carbonate filters with defined pore sizes using pressurised N2
gas at temperatures above the phase transition temperature
[3]. The production of a sterile preparation using this method
is possible if pore sizes of 200 nm are used. However, for most
of the other manufacturing techniques, terminal sterilisation
is still required and the susceptibility of the liposomes to
various chemical and physical degradation mechanisms hasrendered conventional sterilisation techniques unsuitable.
Some of the main degradation pathways include oxidation,
hydrolysis, phase transition and aggregation. In the following
sections, the various modes of liposomal degradation will be
explained before the discussion of the advantages and dis-
advantages of conventional, as well as a novel sterilisation
strategy of liposomal formulations.
2.1. Lipid peroxidation
Lipid peroxidation is the oxidative degradation of lipids and
liposomes, in particular, are easily oxidised even in absence of
specific oxidants. It has been reported that radicals, such as O2

and OH (often resulting from the ionisation of water due
to irradiation) are involved in the lipid peroxidation of
lipid bilayer membranes, especially for those containing
cholesterol and phospholipids with a high content of poly-
unsaturated fatty acid chains [1].
Both radicals can interact with the unsaturated fatty acids
and initiate the free radical chain reaction which leads to lipid
peroxidation as illustrated in Fig. 1. Alternatively, the super-
oxide radical can damage the liposomal membrane by
generating OH and O2
 which will directly oxidise the unsat-
urated fatty acids [4]. The hydroxyl radical can also damage
the membrane directly by incorporating itself into the double
bonds of the unsaturated fatty acid chains [5]. Lipid peroxi-
dation involves the formation of conjugated dienes and
malondialdehyde and results in membrane modifications
such as permeability, rigidity and conformational changes
which can reduce the shelf-life of the liposomes [6].
2.2. Liposomal hydrolysis
Research has shown that hydrolysis of both saturated and
unsaturated phospholipids are mainly catalysed by OH and
Hþ, with OH catalysed hydrolysis being more dominant than
Hþ catalysed hydrolysis [7]. In the presence of water, phos-
pholipids can hydrolyse into fatty acids and lysophospholi-
pids which are further hydrolysed into glycerophospho-
compounds and fatty acids.
The products of hydrolysis, namely lysophospholipids can
increase the membrane permeability of the liposomes signif-
icantly, even at low concentrations. The incorporation of the
resultant fatty acids in the liposomal membranes will pro-
mote fusion of the liposomes which will lead to leakage of
contents [8]. The fatty acids can also influence the phase
transition temperature and hence stability of the liposomal
preparation in a pH-dependentmanner. This will be discussed
in Section 2.3.
Rate of hydrolysis is influenced by pH, temperature and
buffer concentration [9]. Fortunately, studies by Mustafa et al
have shown that hydrolytic rate is relatively low at physio-
logical pH hence the parenteral liposomes will not be sub-
jected to hydrolysis significantly when injected into the
bloodstream. Similarly, hydrolytic rate is found to be inde-
pendent of ionic strength hence addition of tonicity adjusting
agent NaCl in parenteral liposome formulation should not
predispose the preparation to hydrolytic degradation. How-
ever, the same studies conducted show that addition of buffer
(e.g. acetate and citrate), a crucial component of parenteral
Fig. 1 e Schematic representation of the key procedures involved in dense gas technique.
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preparation. The same studies have also concluded that an
increase in temperature can directly lead to an increase in the
hydrolytic rate.
2.3. Phase transition
Phase transition of liposomes occurs when the physical state of
the lipid bilayer changes from an ordered gel conformation
(with fully extended hydrocarbon chains) to a disordered
liquid-crystalline state (randomly oriented hydrocarbon
chains). Factors that promote phase transition of the lipid
bilayer membrane include high temperature, as well as factors
that can lower the phase transition temperature (Tc) of the
phospholipids [10]. Transition of the lipid bilayer membranes
from gel to liquid-crystalline state is governed by Tc, which is
the temperature at which the ordered packing of the lipid
bilayer membrane will be lost and the membrane fluidity will
increase substantially. Factors influencing Tc include pH, con-
centration of free fatty acids and cholesterols in the bilayers.
The main significance of phase transition is that the flexibility
and permeability of the lipid bilayer membrane will increase
when it undergoes phase transition, causing it to become
transiently leaky and the encapsulatedmaterials to be released.
At low pH, the incorporated fatty acids relieve the crowd-
ing of phospholipid polar groups, permitting the phospholipid
acyl chains to pack more closely together hence Tc increases.
At high pH, the free fatty acids are deprotonated and this will
generate a negative charge density in the bilayer surface
which results in a repulsive effect between the phospholipidacyl chains that lowers the Tc [10]. Other factors contributing
to a lower Tc include an increase in free fatty acid concen-
tration and a decrease in cholesterol concentration, both of
which can result from certain sterilisation procedures which
will be discussed later.
2.4. Aggregation
Liposomes are thermodynamically unstable colloidal system
and they tend to aggregate over time and when the Van der
Waals attractive (VA) forces are stronger than the electrical
double layer repulsive forces (VR) that exist between
approaching vesicles, as dictated by the theory of colloidal
stability. Factors that can affect the degree of aggregation
include temperature, ionic strength and surface charge of the
liposomeswhich can be quantified using zeta potential (z). It is
postulated that at high temperatures, the heat energy of the
lipid bilayer membrane is sufficient to overcome the potential
barrier of aggregation Vmax, hence the colloidal system tends
towards aggregation [11].
A major problem from aggregation of liposomes is the
destabilisation of the lipid bilayer membrane and the subse-
quent release of entrapped content [11]. Aggregation of the
liposomes will also lead to fusion and precipitation of the
vesicles, hence product destabilisation. Unlike other conven-
tional parenteral products, liposomal formulations cannot
incorporate dispersing agents, a common formulation addi-
tive in parenteral preparations to prevent aggregation,
because these agents will insert themselves into the lipid
bilayer membrane and induce formation of pores, causing
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vesicles at higher concentrations [12].3. Conventional sterilisation techniques
Bearing in mind the unique composition and properties of li-
posomes hence their susceptibility to the aforementioned
degradation mechanisms, it is important to note that condi-
tions required in conventional sterilisation techniques (all
except filtration) can be detrimental to the stability of the
liposomal preparations. To discuss the feasibility of conven-
tional sterilisation techniques in liposomal preparation,
Table 1 has been included as a summary on the various lim-
itations and advantages of the conventional sterilisation
techniques in the manufacturing of conventional sterile
dosage forms, with emphasis on the more recent dosage form
of liposomes.
3.1. Filtration
This method of sterilisation involves the filtering of liposome
preparations through sterile filtration units under pressure.
Screen filters made from polycarbonate or depth filters made
from cellulose acetate can be used to retain particles that are
larger than 200 nm, allowing liposomes smaller than 200 nm
to pass through. This sterilisation technique is suitable
for thermolabile products, which include liposomes, since it
does not involve any form of heating nor conditions that can
result in the formation of degradation products or leakage
of liposomal contents associated with the other terminal
sterilisation techniques. One drawback of this technique is
that filtration must be performed under aseptic conditions
and is a relatively expensive method since it requires equip-
ment to work under high pressure, which could be above
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Elevated pSome may contend that the size restriction limits the
applicability of this terminal sterilisation technique. However,
this limitation is insignificant in manufacturing liposomes for
parenteral usage since a small vesicle size (of <600 nm, with
an average of 300 nm) is recommended to minimise compli-
cations such as retention and trapping of the vesicles in the
narrower capillaries (e.g. in the lungs). For preparations of size
range between 200 and 300 nm, the formulations can be
heated above the phase transition temperature so that they
can pass through the filter pores in their less rigid spherical
conformations [14].
Filtration sterilisation is relatively time-consuming and not
efficient for removal of viruses [15]. The choice of tight filter
holders and filtration units are essential to the sterility of the
preparations, since the external pressure exerted on the
liposomal dispersion might displace the filter holders slightly
causing the assembly to be leaky. Studies have shown that
polycarbonate membranes are less effective in ensuring the
sterility of the preparations, as compared to Milex and Min-
isart filtration units [14]. The limitations of this technique
have prompted research of the other sterilisation techniques.
Unfortunately, all the other conventional techniques result in
the formation of degradation products via the aforementioned
degradation pathways.
3.2. Gamma (g) irradiation
This sterilisation technique achieves microbial death pri-
marily through the degradation of microbial DNA and
disruption of the microbial membranes via free radical for-
mation. Although g-irradiation is an effective sterilisation
method for certain medicaments and surgical equipment, it
cannot be used in liposome sterilisation. By the aforemen-
tioned mechanism of free radical formation, the unsaturated
phospholipids of liposomes are subjected to peroxidation
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duces OH, while irradiation of phospholipids produces
O2
 [5].
In addition to lipid peroxidation, irradiation-induced lipo-
somal degradation is also attributed to the free radical phos-
pholipid fragmentation [16]. Acidic degradation products
resultant of the fragmentation process include phosphatidic
acid and free fatty acids fragmented from the unsaturated
phospholipids (mainly phosphatidylglycerol) can contribute
to a pH reduction in the liposomal preparation [17]. Compared
to other parenteral preparations, liposomes are especially
susceptible to irradiation-induced degradation because of the
synergism between the two degradation pathways. It has also
been shown that the presence of fragmentation products can
promote lipid peroxidation [16].
While several studies have shown that oxidation can be
minimised by adding antioxidants (e.g. chelating agents)
which are common additives of conventional parenteral for-
mulations, and using an inert and light-resistant storage at-
mosphere which helps to enhance the antioxidants’
effectiveness, thesemeasures do not suffice in eradicating the
extensive lipid peroxidation sustained from the g-irradiation.
Related studies have shown that reducing agents such as
conventional antioxidants and trehalose sugars can disrupt
the radical formation process. The use of chelating agents can
inactivate the transition metals in the liposomal preparations
from mediating the radical formation process. More recent
studies have shown that removal of water via freeze-drying
can reduce the formation of OH hence reducing the
irradiation-induced liposomal damage [18]. Freeze-drying is
also a preferentialmethod for preparing lyophilised liposomes
because these are thermolabile products and the conditions
used in freeze-drying do not involve heat.
The removal of oxygen, a common practice adopted to
minimise irradiation-induced damage in parenteral formula-
tions, is ineffective in liposomal preparation because the
fragmentation mechanism is promoted in absence of oxygen
[16]. Fortunately, g-irradiation might still be applicable for the
sterilisation of liposomes containing solid saturated phos-
pholipids [19]. In solid preparations, the absence of water
which is amajor source of the hydroxyl radicals, will suppress
the oxidative degradation induced by the irradiation process
[18].
Oxidative degradation can be reduced by freezing or
freeze-drying liposomes prior to irradiation (a common tech-
nique used in conventional parenteral product formulation to
minimise undesired effects of g-irradiation), since radical
movement is reduced significantly in the frozen or lyophilised
liposomes. However, it is important to note that irradiation-
induced degradation of the lyophilised phospholipids might
still occur due to presence of residual water which serves as
the source of free radicals. It has been shown that when li-
posomes are irradiated in a frozen state, there is no apparent
phospholipid and cholesterol degradation given that water
molecules are a main source of free radicals [20]. Using
another analytical method, another research group has re-
ported irradiation-induced degradation of solid/frozen/
lyophilised saturated phospholipids and attributed this to the
presence of residual water in the lyophilisates which renders
the lyophilisates prone to indirect radical attack [17].3.3. Saturated steam sterilisation
Unlike g-irradiation, saturated steam sterilisation does not
pose problems of lipid peroxidation since it occurs in absence
of air, thus oxygen, preventing free radical formation. It is
hypothesised that the high sterilisation temperature has
reduced the concentration of dissolved oxygen in the lipo-
somal dispersion insofar as oxidative degradation is inhibited
[21] and that peroxidation will occur under autoclaving con-
ditions because it is a temperature-dependent process [13].
Cholesterol hydrolysis is also an insignificant contributor
to liposomal degradation in this sterilisation technique.
Instead, terminal steam sterilisation of liposomal prepara-
tions (15e20 min at 121 C) is faced with problems common to
conventional parenteral emulsions, namely hydrolytic
degradation of phospholipids and vesicle aggregation; con-
ventional parenteral emulsions are observed to undergo hy-
drolysis and cracking when autoclaved. An additional
problem unique to liposomes is the resultant leakage of
encapsulated contents [22].
Under this sterilisation technique, condensed steam
transfers large amount of heat to the liposomal preparations
in order to kill the microorganisms. However, a side effect of
this heat transfer is the acceleration of the hydrolysis in the
preparations given that hydrolytic rate is directly influenced
by temperature. The increase in temperature also promotes
aggregation in accordance with the explanations provided in
Section 2.4. Finally, content leakage will result from the hy-
drolysis- and aggregation-induced fusion of the liposomes.
The increased membrane permeability following the phase
transition of the membrane at the autoclaving temperature
(which is usually above Tc) also contributes to the content
leakage [21].
However, it has been shown that terminal steam steri-
lisation can still be a viable option in liposome formulation
processes by limiting the hydrolytic degradation with the
proper choice of buffer composition and pH [21,22]. It is also
concluded that rate constant of hydrolysis is lowest at pH 6.5
and decreases with lower buffer concentration [7]. Hydrolysis
of the phospholipids follows Arrhenius kinetics, whereby rate
constant increases with temperature. It is concluded that
autoclaving at neutral pH does not result in significant hydro-
lytic degradation whereas substantial hydrolytic degradation is
observed at pH 4 [21]. Aggregation of liposomes depends on the
liposomal dispersion used (i.e. type, charge of phospholipids
and buffer composition); hence, it can be minimised with the
right composition of liposomal dispersion.
3.4. Dry heat sterilisation
Dry heat sterilisation is generally unsuitable for
manufacturing liposome-based formulations because these
formulations are usually prepared in aqueous forms which
will evaporate and become unstable when subjected to the
high temperature and long exposure time of dry heat steri-
lisation. The extreme heat will destabilise the formulations by
promoting phase transition. A primary mechanism of action
for dry heat involves oxidation, which is unfortunately, one
main degradation pathway for the unsaturated lipids found in
liposomes.
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Ethylene oxide, being an electrophile, will react with the
strongly nucleophilic endocyclic nitrogen atoms in DNA
commonly via a Substitution Nucleophilic Bimolecular (SN2)
mechanism (Ehrenberg et al, 1981). Ionisation of the NH2
groups on the nucleic acid molecule (in the presence of water)
produces N that function as the nucleophile attacking the
carbon on ethylene oxide, giving rise to an alkylatedmolecule.
Unlike the saturated steam and dry heat sterilisation
techniques, this chemical ‘cold’ sterilisation technique uti-
lising ethylene oxide vapours can be used in sterilisation of
liposomes which are heat-sensitive preparations. Another
advantage is that this technique does not alter the vesicle size
[23]. Ethylene oxide is an alkylising agent for bacterial proteins
and genetic material hence can serve as an effective wide-
spectrum anti-bacterial; it is also effective against viruses.
Unlike the other techniques, this does not engender any of the
degradation mechanisms mentioned earlier.
The use of ethylene oxide in terminal sterilisation of
parenteral formulations must be carried out with caution
because residues from an incomplete removal of ethylene
oxide vapours and other chemical agents can still pose serious
problems of flammability, carcinogenicity and mutagenicity
[21]. Therefore, parenteral preparations (including liposomes)
that are sterilised using ethylene oxide must be degassed
thoroughly after sterilisation [23]. It is important to note that
this method is not applicable for aqueous liposomal prepa-
rations and mainly for lyophilised liposomes which can be
easily reconstituted using water for injection [18].
3.6. Ultraviolet (UV) sterilisation
UV sterilisation has limited use in the sterilisation of paren-
teral formulations because UV light, unlike g-rays, has poor
penetration power and is usedmainly for surface sterilisation.
Besides, UV sterilisation is not applicable for liposomal
preparations because its conditions induce substantial
liposomal degradation. It is observed that UV induces free
radical formation, causing lipid peroxidation and subse-
quently, increased membrane permeability [24]. The forma-
tion of the free radicals has been attributed to processes such
as one-electron redox reactions, high-energy radiation
and photolysis, and thermal homolysis of the bonds [24].
Similar to g-irradiation, rate of free radical formation is
dependent on the degree of unsaturation of the liposomal
preparations [25].4. Aseptic manufacturing
Besides terminal sterilisation, aseptic manufacturing pro-
cesses can facilitate the formulation of sterile parenteral
products including liposomes. Raw materials (including
organic and aqueous solvents, the natural sources of lipid
components as well as other additives such as buffers) are
sterilised after passing 200 nm filters [26]. The equipment can
be autoclaved and sterilised. Subsequently, the liposomes are
prepared via procedures mentioned in Section 2 and then
assembled into their containers via aseptic filling. Duringaseptic filling, the other potential sources of contamination
(which include the environmental air, operating personnel
and the water for drainage) are critically controlled by per-
forming the filling process on work stations that have been
designed to protect the previously sterilised component and
equipment. These work stations are, in turn, located in clean
rooms (Class-100 environments) which have been designed to
facilitate and maintain thorough sterility during the entire
operation of aseptic manufacturing.
Unlike terminal sterilisation which is an active process of
destroying the contaminants within the finished product,
aseptic filling, and aseptic manufacturing, is essentially a
passive process of avoiding further contamination of the final
preparation. Therefore, there is still a risk of contamination in
aseptic manufacturing especially if the initial raw materials
are not sterilised adequately. In the aseptic manufacturing of
liposomes, the natural sources of lipid components can only
be subjected to filtration due to physicochemical degradation
and other considerationsmentioned earlier in the discussions
of the various sterilisation techniques. Since the filter mem-
branes can only retain the particles larger than 200 nm, the
final formulation will be contaminated with the viruses pre-
sent in the initial ingredients. Likewise for all parenteral for-
mulations made from components that cannot be terminally
sterilised by non-filtration means, the contaminants residing
in the ingredients or introduced during the manufacturing
processes cannot be removed from the final product even
when aseptic manufacturing is performed.
Unlike terminal sterilisation, the degree of sterility assur-
ance cannot be assessed for aseptic manufacture. In view of
this and the possibility of contamination, current regulatory
thinking (particularly the FDA) regards aseptic manufacture
as a process of last resort. However, the problem of contami-
nation during aseptic filling can be circumvented by incorpo-
rating ultrafiltration at the end of the manufacturing process
[6]. As for the contaminants (including viruses) initially pre-
sent in the ingredients that cannot be filtered away, the dense
gas technique which is a more recently adopted method of
preparing liposomes from lipid and aqueous components can
perhaps be introduced at the beginning of the manufacturing
process.5. Dense gas technique
Dense gas technique is a newer method of manufacturing li-
posomes that eliminates the need for terminal sterilisation. In
the supercritical liposome method described by [27], instead of
dissolving the lipid components inanorganic solventwhich can
be apotential source ofmicrobial contamination, a supercritical
fluid suchasCO2 isused for dissolutionof the lipid components.
This supercritical fluid possesses solvent properties parallel to
that of liquids hence it is able to dissolve the lipid components
with ease [15]. Similar to the process mentioned previously
under Section2, themixture is then combinedwith theaqueous
component and the supercritical solvent is evaporated after
pressure reductions [28] as illustrated in Fig. 1 below.
CO2 is utilised in dense gas processing because it presents
advantages of non-flammability, non-toxicity (overcoming
the limitation of the chemical ‘cold’ sterilisation technique),
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(200e300 bar and 60 C) required for phase transition. More
importantly, the antimicrobial properties of CO2 eliminate the
need for terminal sterilisation [1,29]. Due to its low viscosity
and elevated diffusion rate, the supercritical CO2 can pass
through the microbial cell walls and membranes easily and
dissolve in water to form H2CO3, increasing the acidity of the
bacterial cytoplasm up to pH 3e3.2 and inactivating enzymes
crucial for cellular metabolism. The carbonic acid can then
ionise into CO3
2 and HCO3
 which contribute to intracellular
precipitation of salts, further contributing to microbial death
[30]. Supercritical CO2 has been proven to be effective in
inactivating viruses via viral elimination and inactivation [31].
This process is gentle and will not result in formation of
degradation products, hence overcoming the limitations found
in the autoclaving and g-irradiation sterilisation techniques.
Due to its high density, the supercritical CO2 has deep pene-
trating properties; hence, this manufacturing method can
achieve thorough sterility [32] throughmechanical cell rupture
and physiological deactivation [29]. However, supercritical CO2
is less effective against spores compared to vegetative cells. In
fact, the use of supercritical CO2 is so effective that this
technique can achieve Sterility Assurance Levels of 107. This
advanced formulation method allows the production of lipo-
somes sized up to 1500 nm in diameter, unlike filtration steri-
lisationwhich restricts liposomal sizes to 200nm [28]. However,
this advanced technique is incapable of inactivating bacterial
spores unless used in combination with peracetic acid as an
additive [32]. Peracetic acid degrades to acetic acid and water
and thus posing no concern of toxicity. An additional limitation
of this technique is that the solid components of the super-
critical CO2 readily clog up the nozzle and other equipment [15].6. Conclusion
Liposomes have great potential as parenteral drug delivery
systems however due to the unique properties and composi-
tion of liposomes, their amphiphilicity allows the encapsula-
tion of both lipid-soluble and water-soluble substances.
However, sterilisation of liposomal preparations remains an
issue, with each technique presenting its own limitations.
Although filtration does not cause any degradation, it imposes
size restrictions on the final products; saturated steam steri-
lisation may be cheap and easy but it can cause product
degradation, likewise for g-irradiation. Though chemical
‘cold’ sterilisation does not affect product integrity, residual
sterilants can cause toxicity issues. As for UV sterilisation and
dry heat sterilisation, they are completely inappropriate in
liposomal manufacturing. While aseptic manufacturing and
filtration are the most commonly utilised methods of pro-
ducing parenteral liposomes, the procedures involved are
time-consuming and the equipment is extremely expensive
and difficult to maintain. This impedes the scaling-up of
parenteral liposomal manufacturing and ascribes a high
cost to such preparations. Although a combination of the
dense gas technique, aseptic manufacturing and filtration
can perhaps be used to produce sterile liposomal formula-
tions, this combinatorial manufacturing process may be toocumbersome and time-consuming. Hence, there remains a
need for the development of a widely applicable terminal
sterilisation technique, one that is efficient, cost-effective and
can maintain the physicochemical stability and encapsulated
content of the preparation.r e f e r e n c e s
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